- Home
- ALXO vs MX Comparison
ALXO vs MX Comparison
Compare ALXO & MX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALXO | MX |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.8M | 179.7M |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ALXO | MX |
|---|---|---|
| Price | $1.24 | $2.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $4.60 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 758.5K |
| Earning Date | 11-10-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.36 | ★ 43.06 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $178,860,000.00 |
| Revenue This Year | N/A | $5.39 |
| Revenue Next Year | N/A | $6.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.86 | $2.18 |
| 52 Week High | $2.66 | $9.86 |
Technical Indicators
Market Signals| Indicator | ALXO | MX |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 34.33 |
| Support Level | $0.86 | N/A |
| Resistance Level | $1.30 | $3.06 |
| Average True Range (ATR) | 0.15 | 0.13 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 81.20 | 3.63 |
Price Performance
Historical ComparisonAbout ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The Company operates within a single operating segment, Power Solutions business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.